Combining the Power of miRNAs and Nanotechnology to Prevent Osteoarthritis Progression
miRNAs belong to the category of non-coding RNAs. They block the expression of a gene either by binding to its specific mRNA and degrading it or by preventing the translation of the specific mRNA. More than 1900 miRNAs have been discovered to date in humans, and many of them have been implicated in various human diseases. Changes in the expression of miRNA have been involved in diseases like cancer, obesity, cardiovascular diseases, and osteoarthritis (OA).
Several miRNAs have been identified that are differentially expressed in OA . One of the first miRNA that has been linked to OA pathology is miRNA-140.
Several miRNAs have been identified that are differentially expressed in OA . One of the first miRNA that has been linked to OA pathology is miRNA-140.
GO Prime with only $1.49 now
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03